 | |
| |
| |  |
| | Relenza royalties up for Biota |  | Tuesday, 9 February 2010
Amanda Ellis
MELBOURNE-based Biota expects a 35.3% jump in Relenza royalties for the December quarter after GlaxoSmithKline revealed quarterly sales hit $A462 million.
You are not logged in or not authorised to view this page.
Get Your FREE 30 Day Trial Now!
|
|
|
OR
Click here to read the rest of today's news stories.
|
|
| |
|
|
|
